Magnetic resonance imaging in the diagnosis of cardiac amyloidosis

Main Article Content

Laura C. Dragonetti
Leandro J. Carballo
Verónica Flores
Marcelo A. Pietrani
Ricardo D. García Mónaco

Abstract

Cardiac magnetic resonance imaging (MRI) is a noninvasive method of image that provides information about the anatomy, function and tissue characterization, becoming very useful in the diagnosis and differentiation of infiltrative disorders such as amyloidosis. Cardiac amyloidosis (CA) is a restrictive cardiomyopathy result of amyloid deposition in the heart. MRI findings include myocardial hypertrophy with positive late gadolinium enhancement (LGE) in the left ventricle (LV) associated with the altered kinetics of gadolinium and additional findings as pleural and pericardial effusion that support the diagnosis. We report the case of a patient diagnosed with amyloidosis showing the characteristic MR findings in this pathology

Downloads

Download data is not yet available.

Article Details

Section

Medicina interna en imágenes

How to Cite

1.
Dragonetti LC, Carballo LJ, Flores V, Pietrani MA, García Mónaco RD. Magnetic resonance imaging in the diagnosis of cardiac amyloidosis. Rev Hosp Ital B.Aires [Internet]. 2015 Dec. 30 [cited 2026 Apr. 27];35(4):128-30. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/701

References

American College of Cardiology Foundation Task Force on Expert Consensus Documents, Mark DB, Berman DS, Budoff MJ, et al. ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010;55(23):2663-99. DOI: https://doi.org/10.1016/j.jacc.2009.11.013

Penugonda N. Cardiac MRI in infiltrative disorders: a concise review. Curr Cardiol Rev. 2010 May;6(2):134-6. DOI: https://doi.org/10.2174/157340310791162668

Thomson LE. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: diagnostic value of a typical pattern of late gadolinium enhancement. J Am Coll Cardiol. 2008;51(10):1031-2. DOI: https://doi.org/10.1016/j.jacc.2007.11.043

Mohty D, Damy T, Cosnay P, et al. Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis. 2013;106(10):528-40. DOI: https://doi.org/10.1016/j.acvd.2013.06.051

vanden Driesen RI, Slaughter RE, Strugnell WE. MR findings in cardiacamyloidosis. AJR Am J Roentgenol. 2006 Jun;186(6):1682-5. DOI: https://doi.org/10.2214/AJR.04.0871

Kwong RY, Falk RH. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005 Jan 18;111(2):122-4. DOI: https://doi.org/10.1161/01.CIR.0000153623.02240.20

Maceira AM, Prasad SK, Hawkins PN, et al. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson. 2008 Nov 25;10:54. DOI: https://doi.org/10.1186/1532-429X-10-54